Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917816 (
mental retardation
)
15,867
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The syndromes of thyroid hormone resistance may affect overall or only some tissues. The generalized resistance is an inherited disease which involves a familial eumetabolic or hypometabolic goiter, increased free thyroid hormones with normal or elevated plasma TSH levels; children may present
mental retardation
, deafness, short stature and delayed bone age. The disease is frequently misdiagnosed. In vivo and in vitro tests may be used to assess the diagnosis. The defect of increment of
sex hormone-binding globulin
after administration of T3 may be useful in the demonstration of the disease. Therapy uses high T4 or T3 doses in hypometabolic patients. The generalized thyroid hormone resistance could be linked to abnormalities at the T3 receptor and c-erb A gene level, as a consequence of different point mutations or deletions involving the hormone-binding domain.
...
PMID:Thyroid hormone generalized resistance. 130 19
An X;17 translocation breakpoint was characterised in a 5-year-old female with hypomelanosis of Ito (HI) who exhibits characteristic hypopigmented lesions, psychomotor retardation, and choroid plexus papilloma. A YAC clone containing the locus DXS1 from Xq12 was found by fluorescence in situ hybridisation to cross the translocation breakpoint. Cosmid clones positive for DXS1 were used to identify and clone the translocation junction fragment from the patient's DNA. A chromosome-17-specific DNA fragment was isolated and used to identify cosmid clones crossing the translocation from chromosome 17p13. Exon trapping identified two known genes from chromosome 17: FMR1L2 (the fragile X
mental retardation
syndrome like protein 2) and
SHBG
(human
sex hormone-binding globulin
). Mapping the FMR1L2 and
SHBG
genes showed that neither gene was disrupted by the translocation.
...
PMID:Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma. 919 54
The rat androgen-binding protein/
sex hormone-binding globulin
(ABP/
SHBG
) gene is regulated by promoters P1 and PA. P1 regulates the mRNA encoding secreted ABP/
SHBG
, whereas PA regulates an alternate mRNA which encodes a modified protein that is targeted to the nucleus. Promoter PA is GC rich, consisting of 70-80% GC residues. During routine BLAST sequence analysis it was discovered that this GC-rich region is highly related to the human fragile X-related protein 2 (FXR-2) 5'-untranslated RNA sequence. Furthermore, the nucleotide coding sequence of the initial 14 FXR-2 amino acid residues was identical in the ABP/
SHBG
gene. The 5'-untranslated FXR-2 sequence contains triplet (CGG) repeats, which are also present in the rat ABP/
SHBG
gene. The meiotic instability of CGG repeats in the human fragile X (FMR1) gene causes the fragile X
mental retardation
syndrome. The data presented here suggest that the ABP/
SHBG
and FXR-2 genes overlap with each gene transcribed in the opposite direction. In support of this structure, the human ABP/
SHBG
and the FXR-2 genes map to the same site on chromosome 17. Thus, the ABP/
SHBG
gene contains triplet repeats in the alternate promoter PA. It will be of particular interest to determine if triplet instability affects ABP/
SHBG
gene expression. A triplet instability in the X-linked androgen receptor gene causes spinal and bulbar muscular atrophy.
...
PMID:The rat androgen-binding protein (ABP/SHBG) gene contains triplet repeats similar to unstable triplets: evidence that the ABP/SHBG and the fragile X-related 2 genes overlap. 943 88